- Home
- VAPE vs ENSC Comparison
VAPE vs ENSC Comparison
Compare VAPE & ENSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VAPE
- ENSC
- Stock Information
- Founded
- VAPE N/A
- ENSC 2003
- Country
- VAPE United States
- ENSC United States
- Employees
- VAPE N/A
- ENSC N/A
- Industry
- VAPE
- ENSC Biotechnology: Pharmaceutical Preparations
- Sector
- VAPE
- ENSC Health Care
- Exchange
- VAPE NYSE
- ENSC Nasdaq
- Market Cap
- VAPE 6.0M
- ENSC 5.2M
- IPO Year
- VAPE N/A
- ENSC N/A
- Fundamental
- Price
- VAPE $57.59
- ENSC $2.29
- Analyst Decision
- VAPE
- ENSC
- Analyst Count
- VAPE 0
- ENSC 0
- Target Price
- VAPE N/A
- ENSC N/A
- AVG Volume (30 Days)
- VAPE 704.7K
- ENSC 92.2K
- Earning Date
- VAPE 08-13-2025
- ENSC 08-13-2025
- Dividend Yield
- VAPE N/A
- ENSC N/A
- EPS Growth
- VAPE N/A
- ENSC N/A
- EPS
- VAPE N/A
- ENSC N/A
- Revenue
- VAPE $3,282,424.00
- ENSC $6,224,081.00
- Revenue This Year
- VAPE N/A
- ENSC N/A
- Revenue Next Year
- VAPE N/A
- ENSC $1,381.48
- P/E Ratio
- VAPE N/A
- ENSC N/A
- Revenue Growth
- VAPE 33.28
- ENSC 256.35
- 52 Week Low
- VAPE $5.60
- ENSC $1.62
- 52 Week High
- VAPE $82.88
- ENSC $14.67
- Technical
- Relative Strength Index (RSI)
- VAPE N/A
- ENSC 55.64
- Support Level
- VAPE N/A
- ENSC $2.18
- Resistance Level
- VAPE N/A
- ENSC $2.36
- Average True Range (ATR)
- VAPE 0.00
- ENSC 0.16
- MACD
- VAPE 0.00
- ENSC 0.01
- Stochastic Oscillator
- VAPE 0.00
- ENSC 74.42
About VAPE CEA INDUSTRIES INC
CEA Industries Inc through its subsidiary is focused on selling environmental control and other technologies and services to the Controlled Environment Agriculture ("CEA") industry. The company provides integrated mechanical, electrical, and plumbing ("MEP") engineering design, proprietary and curated environmental control equipment, and automation offerings that serve the CEA industry. The Company has one operating segment that is dedicated to the manufacture and sale of its products.
About ENSC Ensysce Biosciences Inc.
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.